Results 51 to 60 of about 2,631 (193)
American Journal of Hematology, EarlyView.ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez +17 more
wiley +1 more source
Dexametasona en la prevención de náuseas y vómitos posoperatorios en pacientes histerectomizadas
Medisur, 2019 Fundamento: La dexametasona, corticoestoride de acción prolongada, es un fármaco con características que favorecen su uso en el tratamiento de las náuseas y los vómitos en determinadas circunstancias, sin embargo, su utilidad para prevenir las náuseas y ...
Roberto González Castilla +2 more
doaj
American Journal of Hematology, EarlyView.ABSTRACT Quizartinib is a tyrosine kinase inhibitor with single agent activity in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and has demonstrated efficacy in first‐line therapy when combined with intensive chemotherapy in both FLT3 ITD‐negative and positive AML.
Teresa Bernal +29 more
wiley +1 more source
Revista Universitas Medica, 2016 Introducción: A pesar de los adelantos en la anestesiología actual, aún continúan presentándose náuseas y vómito en el postoperatorio (NVPO) como una de las complicaciones más frecuentes con una incidencia que oscila entre el 4,6 % y el 49,0 %. Objetivos:
Fritz Eduardo Gempeler Rueda +5 more
doaj
American Journal of Hematology, EarlyView.ABSTRACT Dordaviprone is a first‐in‐class small‐molecule imipridone. In preclinical studies, it is active against leukemia cells harboring a TP53 mutation or complex karyotype and leukemia stem cells while sparing normal bone marrow cells. This study aimed to determine the safety of dordaviprone maintenance after allogeneic hematopoietic cell ...
Vijaya Raj Bhatt +8 more
wiley +1 more source
The 9th International RASopathies Symposium
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT The RASopathies are a group of congenital disorders with overlapping clinical manifestations that are caused by pathogenic germline or early somatic variants that result in the hyperactivation of the RAS/mitogen‐activated protein kinase (MAPK) signaling pathway.
Pau Castel +41 more
wiley +1 more source
Estudo piloto de utilização de medicamentos antieméticos em uma unidade de oncologia pediátrica
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2019 Objetivo: Avaliar a utilização de medicamentos antieméticos em uma unidade de oncologia pediátrica de um hospital universitário de Porto Alegre através de um estudo piloto.
NAIANE ROVEDA MARSILIO +2 more
doaj
Revista Reumatología al Día, 2022 Paciente femenina de 38 años, con diagnóstico de Lupus Eritematoso Sistémico (LES) de 6 años de evolución que presentó dolor abdominal recurrente, nauseas y vómitos.
Mario Moreno Alvarez +1 more
doaj
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT Autosomal recessive loss‐of‐function variants in PPP1R13L cause an ultra‐rare cardiocutaneous syndrome characterized by rapidly progressive arrhythmogenic cardiomyopathy (ACM). PPP1R13L encodes iASPP, which has two potentially overlapping mechanisms driving ACM as both a regulator of NFκB‐mediated inflammation and a binding partner within the ...
Aaron Renberg +9 more
wiley +1 more source
Gestão das Náuseas e Vómitos Pós-operatórios: Scoping Review
RevSALUSIntrodução: As náuseas e vómitos pós-operatórios (NVPO) são efeitos comuns e indesejáveis associados às cirurgias realizadas sob anestesia geral.
Cristina Pinto +5 more
doaj +1 more source